Varicose Vein Treatment Devices Market Report 2025

This Varicose Vein Treatment Devices market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The varicose vein treatment devices market size has grown strongly in recent years. It will grow from $1.31 billion in 2024 to $1.43 billion in 2025 at a compound annual growth rate (CAGR) of 9%. The growth during the historical period can be attributed to factors such as the aging population, increased awareness of varicose veins, greater demand for minimally invasive procedures, higher healthcare spending, and the rise in lifestyle-related diseases.

The varicose vein treatment devices market size is expected to see strong growth in the next few years. It will grow to $2.0 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The projected growth for the forecast period is driven by factors including increased public awareness, higher disposable incomes, a growing prevalence of varicose veins, expansion of healthcare infrastructure in emerging markets, and an increasing obese population. Key trends during this period include a shift toward outpatient treatments, the use of laser and radiofrequency technologies, advancements in technology, greater adoption of ambulatory care centers, and a rising demand for home-based treatment devices.

The rising incidence of obesity is expected to drive the growth of the varicose veins treatment devices market. Obesity is a medical condition characterized by excessive body fat, which can lead to serious health problems such as diabetes, cardiovascular diseases, and joint issues. The growing obesity rates are primarily caused by poor dietary habits, reduced physical activity, and environmental factors that promote unhealthy eating. Additionally, socio-economic conditions, genetics, and mental health factors significantly contribute to the condition’s prevalence. Varicose vein treatment devices help improve the quality of life for individuals with obesity by alleviating vein-related complications, enhancing blood circulation, reducing pain and swelling caused by excess weight, and supporting better mobility and vascular health. For example, in March 2023, the World Heart Foundation reported that approximately 2.3 billion adults and children worldwide are obese or overweight, and this number is expected to increase to 2.7 billion by 2025. As a result, the rising obesity rates are fueling growth in the varicose veins treatment devices market.

Leading companies in the varicose veins treatment devices market are focusing on developing innovative minimally invasive technologies to provide precise treatment with less discomfort and faster recovery for patients. Minimally invasive technologies use small incisions and advanced instruments such as endoscopes and robotic systems to perform procedures with less trauma, reduced recovery times, and lower risks of complications compared to traditional open surgery. For example, in June 2023, Biolitec AG, an Austria-based medical technology company, launched the Elves Radial 2ring Pro laser fiber and the Leonardo 1940 laser for varicose vein treatment. The Elves Radial 2ring Pro laser fiber includes an additional channel for saline solution, enabling veins to be stretched before laser treatment, while the Leonardo 1940 laser’s specific wavelength enhances vein wall absorption, reducing bruising and recovery time. These innovations significantly improve the efficiency and aesthetic results of varicose vein treatments, offering a more effective solution for removing large and twisted veins.

In November 2023, DXI Capital Corp., a Canada-based investment company, acquired V.V.T. Med Ltd. for an undisclosed amount. This acquisition aligns with DXI Capital's strategy to expand its portfolio and strengthen its position in the life sciences market. By acquiring V.V.T. Med Ltd., a manufacturer of devices for varicose vein treatment, DXI aims to capitalize on emerging growth opportunities within the sector. V.V.T. Med Ltd. is an Israel-based company known for its advanced healthcare solutions in the treatment of varicose veins.

Major players in the varicose vein treatment devices market are Medtronic Plc, Boston Scientific Corporation, Teleflex Incorporated, Merit Medical Systems, Lumenis Be Ltd., AngioDynamics Inc., Candela Medical, Alma Lasers, Dornier Medtech, Fotona d.o.o., Sciton Inc., Won Tech Co. Ltd, Quanta System SpA, biolitec Holding GmbH & Co KG, Eufoton SRL, Myovatec Surgical Systems, Chemische Fabrik Kreussler & Co., Ad Rem Technology, VB Devices, Theraclion, and InVera Medical.

North America was the largest region in the varicose vein treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in varicose veins treatment devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the varicose veins treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Varicose vein treatment devices are specialized medical instruments designed to treat swollen, enlarged, and twisted veins, typically in the legs, caused by weakened or malfunctioning valves that result in poor blood circulation. These devices are used to manage or eliminate varicose veins by enhancing blood flow, relieving discomfort, and minimizing complications related to venous insufficiency.

The primary categories of devices used in varicose vein treatment include ablation devices, venous closure products, and others. Ablation devices are medical tools that remove or destroy tissue, often using methods such as heat, cold, or electrical energy. Available treatments include sclerotherapy, endovenous ablation, and surgical ligation and stripping, among others. These treatments are used for both adults and the elderly, with the devices being employed in specialty clinics, hospitals, ambulatory surgical centers, and other healthcare settings.

The varicose vein treatment devices market research report is one of a series of new reports that provides varicose vein treatment devices market statistics, including varicose vein treatment devices industry global market size, regional shares, competitors with varicose vein treatment devices market share, detailed varicose vein treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the varicose vein treatment devices industry. This varicose vein treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The varicose veins treatment devices market consists of sales of injection devices, endovenous laser therapy (EVLT) systems, and compression therapy devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.